ublituximab-xiiy
Brand: BRIUMVI
approved
Quick answer
ublituximab-xiiy (BRIUMVI), is a pharmaceutical active ingredient, associated with TG THERAPEUTICS, INC., with approved status in the US.
Key facts
- INN
- ublituximab-xiiy
- Brand
- BRIUMVI
- Route
- INTRAVENOUS
- Formulation
- INJECTABLE
- Originator
- TG THERAPEUTICS, INC.
Frequently asked questions
What is ublituximab-xiiy?
ublituximab-xiiy (BRIUMVI), is a pharmaceutical active ingredient, associated with TG THERAPEUTICS, INC., with approved status in the US.
What is the brand name for ublituximab-xiiy?
BRIUMVI is a marketed brand name for ublituximab-xiiy. Check FDA Drugs@FDA for the current US label holder.